These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29231918)

  • 1. [Systemic treatment of early breast cancer - current state of knowledge after the conference St Gallen 2017].
    Sarosiek T
    Pol Merkur Lekarski; 2017 Nov; 43(257):232-236. PubMed ID: 29231918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adjuvant chemotherapy for primary breast cancer--review of 1998 St. Gallen's conference].
    Taguchi T
    Gan To Kagaku Ryoho; 1999 Aug; 26(9):1227-41. PubMed ID: 10478174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic therapy of breast cancer: practice guideline].
    Horváth Z; Boér K; Dank M; Kahán Z; Kocsis J; Kövér E; Pajkos G; Pikó B; Rubovszky G; Eckhardt S
    Magy Onkol; 2016 Sep; 60(3):241-57. PubMed ID: 27579723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highlights from the 15th St Gallen International Breast Cancer Conference 15-18 March, 2017, Vienna: tailored treatments for patients with early breast cancer.
    Morigi C
    Ecancermedicalscience; 2017; 11():732. PubMed ID: 28491135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
    Curigliano G; Burstein HJ; Winer EP; Gnant M; Dubsky P; Loibl S; Colleoni M; Regan MM; Piccart-Gebhart M; Senn HJ; Thürlimann B; ; André F; Baselga J; Bergh J; Bonnefoi H; Brucker SY; Cardoso F; Carey L; Ciruelos E; Cuzick J; Denkert C; Di Leo A; Ejlertsen B; Francis P; Galimberti V; Garber J; Gulluoglu B; Goodwin P; Harbeck N; Hayes DF; Huang CS; Huober J; Hussein K; Jassem J; Jiang Z; Karlsson P; Morrow M; Orecchia R; Osborne KC; Pagani O; Partridge AH; Pritchard K; Ro J; Rutgers EJT; Sedlmayer F; Semiglazov V; Shao Z; Smith I; Toi M; Tutt A; Viale G; Watanabe T; Whelan TJ; Xu B
    Ann Oncol; 2017 Aug; 28(8):1700-1712. PubMed ID: 28838210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).
    Bueno-de-Mesquita JM; van Harten WH; Retel VP; van 't Veer LJ; van Dam FS; Karsenberg K; Douma KF; van Tinteren H; Peterse JL; Wesseling J; Wu TS; Atsma D; Rutgers EJ; Brink G; Floore AN; Glas AM; Roumen RM; Bellot FE; van Krimpen C; Rodenhuis S; van de Vijver MJ; Linn SC
    Lancet Oncol; 2007 Dec; 8(12):1079-1087. PubMed ID: 18042430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The curability of breast cancer and the treatment of advanced disease.
    Guarneri V; Conte PF
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant systemic therapy for lymph node-negative breast cancer less than or equal to 1 cm.
    Russell CA
    Curr Womens Health Rep; 2002 Apr; 2(2):134-9. PubMed ID: 12116603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time trends in systemic adjuvant treatment for node-negative breast cancer.
    Hébert-Croteau N; Brisson J; Latreille J; Gariépy G; Blanchette C; Deschênes L
    J Clin Oncol; 1999 May; 17(5):1458-64. PubMed ID: 10334531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015).
    Untch M; Harbeck N; Huober J; von Minckwitz G; Gerber B; Kreipe HH; Liedtke C; Marschner N; Möbus V; Scheithauer H; Schneeweiss A; Thomssen C; Jackisch C; Beckmann MW; Blohmer JU; Costa SD; Decker T; Diel I; Fasching PA; Fehm T; Janni W; Lück HJ; Maass N; Scharl A; Loibl S
    Geburtshilfe Frauenheilkd; 2015 Jun; 75(6):556-565. PubMed ID: 26166836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient.
    Goldhirsch A
    Breast; 2013 Aug; 22 Suppl 2():S3-7. PubMed ID: 24074788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conference.
    Rabaglio M; Aebi S; Castiglione-Gertsch M
    Lancet Oncol; 2007 Oct; 8(10):940-9. PubMed ID: 17913663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study.
    Cazzaniga ME; Mustacchi G; Pronzato P; De Matteis A; Di Costanzo F; Floriani I;
    Ann Oncol; 2007 Dec; 18(12):1976-80. PubMed ID: 17761700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. St. Gallen/Vienna 2017: A Brief Summary of the Consensus Discussion about Escalation and De-Escalation of Primary Breast Cancer Treatment.
    Gnant M; Harbeck N; Thomssen C
    Breast Care (Basel); 2017 May; 12(2):102-107. PubMed ID: 28559767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant treatment of breast cancer in 2004. A review of the 8th consensus conference of St. Gallen and new study results].
    Kahlert S; von Koch F; Ditsch N; Untch M
    Gynakol Geburtshilfliche Rundsch; 2004 Apr; 44(2):102-12. PubMed ID: 15073439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies in the adjuvant systemic therapy of endocrine-non-responsive breast cancer.
    Cardoso F; Di Leo A; Piccart MJ
    Cancer Treat Rev; 2002 Dec; 28(6):275-90. PubMed ID: 12470979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013).
    Untch M; Gerber B; Harbeck N; Jackisch C; Marschner N; Möbus V; von Minckwitz G; Loibl S; Beckmann MW; Blohmer JU; Costa SD; Decker T; Diel I; Dimpfl T; Eiermann W; Fehm T; Friese K; Jänicke F; Janni W; Jonat W; Kiechle M; Köhler U; Lück HJ; Maass N; Possinger K; Rody A; Scharl A; Schneeweiss A; Thomssen C; Wallwiener D; Welt A
    Breast Care (Basel); 2013 Jun; 8(3):221-9. PubMed ID: 24415975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.